CD9 and neoplasm: However, whilst the anti‐CD63‐APC or anti‐CD9‐PE fluorescence were well‐detectable in the fractions F16‐F17 in tumour samples (Figure 5b, red, violet lines), it remained at the detection limit in the samples of healthy donors.